ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is CARsgen Therapeutics Holdings Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of 209.39% and Operating profit at 3.37% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -73.62
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -22.86%, its profits have risen by 52.1%
3
Underperformed the market in the last 1 year
- Even though the market (Hang Seng Hong Kong) has generated returns of 8.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -22.86% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CARsgen Therapeutics Holdings Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
CARsgen Therapeutics Holdings Ltd.
-22.86%
2.42
79.55%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
209.39%
EBIT Growth (5y)
3.37%
EBIT to Interest (avg)
-73.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.30
Sales to Capital Employed (avg)
0.05
Tax Ratio
0.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.98
EV to EBIT
-17.80
EV to EBITDA
-20.23
EV to Capital Employed
-27.62
EV to Sales
89.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-34.19%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD -676.4 MM
ROCE(HY)
Highest at -10.57%
DEBTORS TURNOVER RATIO(HY)
Highest at 3.54 times
OPERATING PROFIT(Q)
Highest at HKD -84.97 MM
RAW MATERIAL COST(Y)
Fallen by -4,522% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -135.61 %
PRE-TAX PROFIT(Q)
Highest at HKD -30.02 MM
NET PROFIT(Q)
Highest at HKD -24.66 MM
EPS(Q)
Highest at HKD -0.04
-4What is not working for the Company
CASH AND EQV(HY)
Lowest at HKD 1,251.27 MM
INTEREST(Q)
Highest at HKD 4.2 MM
Here's what is working for CARsgen Therapeutics Holdings Ltd.
Operating Profit
Highest at HKD -84.97 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (HKD MM)
Debtors Turnover Ratio
Highest at 3.54 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Operating Cash Flow
Highest at HKD -676.4 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Pre-Tax Profit
Highest at HKD -30.02 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Pre-Tax Profit
At HKD -30.02 MM has Grown at 89.24%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
Highest at HKD -24.66 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Net Profit
At HKD -24.66 MM has Grown at 91.17%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
EPS
Highest at HKD -0.04
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Debt-Equity Ratio
Lowest at -135.61 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -4,522% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
At HKD 18.39 MM has Grown at 34.9%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for CARsgen Therapeutics Holdings Ltd.
Interest
Highest at HKD 4.2 MM
in the last five periods and Increased by 27.5% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Cash and Eqv
Lowest at HKD 1,251.27 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
